161 results
6-K
EX-99.3
FENC
Fennec Pharmaceuticals Inc
31 Mar 06
Current report (foreign)
12:00am
Institute
Nov 2002
Raymond Hession (1)(2)(4)
Ontario, Canada
Lead Independent Director of the
Board of Directors
Chairman, Ontario Health Quality Council … determined that each member of the Compensation Committee is “independent.”
Report on Executive Compensation
The Compensation Committee submitted
DEF 14A
FENC
Fennec Pharmaceuticals Inc
3 Apr 07
Definitive proxy
12:00am
director of R&M Financial Associates
Sept 2006
Fred H. Mermelstein, PhD (3)(4)
Massachusetts, USA
Lead Independent Director of the Board of Directors … .
The Board has determined that each member of the Compensation Committee is “independent” under SEC, and AMEX rules and Canadian securities laws.
Summary
S-1/A
EX-23.2
6e9w31fppk8jwkovit
9 Feb 11
IPO registration (amended)
12:00am
8-K
EX-99.1
io7dwt0
21 Apr 10
Adherex Announces Additional Financing
12:00am
8-K
dbtrbt9b8 uy4
26 Aug 11
Adherex Announces Completion of Reverse Stock Split and Continuance to British Columbia
12:00am
POS AM
EX-23.2
1t0 i54or7
1 Apr 13
Prospectus update (post-effective amendment)
12:00am
CORRESP
5hrpjb
2 Feb 11
Correspondence with SEC
12:00am